Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
herpetic keratitis
MeSH D016849 - herpetic keratitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007634:
Keratitis
63 Companies
16 Drugs
$
Success rate
D006561:
Herpes simplex
53 Companies
6 Drugs
$
Success rate
D015828:
Viral eye infections
0 Companies
0 Drugs
Success rate
D016849:
Herpetic keratitis
7 Companies
3 Drugs
$
Success rate
D007635:
Dendritic keratitis
3 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Parkedale Pharmaceuticals
Vidarabine
Vira-a
1982-01-01
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
25
%
3/12
Approved:
2
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Taiho Oncology
Tipiracil
,
Trifluridine
Servier
Tipiracil
,
Trifluridine
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use